Author Question: An infant with a CDH also has pulmonary hypertension. Which of the following can be administered to ... (Read 33 times)

bobthebuilder

  • Hero Member
  • *****
  • Posts: 567
An infant with a CDH also has pulmonary hypertension. Which of the following can be administered to relieve this problem?
 
  a. Inhaled nitric oxide (iNO)
  b. Inhaled parasympatholytic agent
  c. 80 helium20 oxygen
  d. Corticosteroids

Question 2

Positive risk factor(s) for the development of kyphoscoliosis include:
 
  1. male gender.
  2. female gender.
  3. taller person.
  4. shorter person.
  a. 1
  b. 2
  c. 2, 3
  d. 1, 4



Sassygurl126

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

A
It has been shown that iNO causes vasodilation and is used to treat pulmonary hypertension.

Answer to Question 2

C
Height and gender are contributing factors for developing kyphoscoliosis. It is more prevalent among females and taller individuals.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

It is believed that humans initially contracted crabs from gorillas about 3 million years ago from either sleeping in gorilla nests or eating the apes.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library